BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Clinical trials for BREAST CANCER (LOCALLY ADVANCED OR METASTATIC) explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER (LOCALLY ADVANCED OR METASTATIC) trials appear
Sign up with your email to follow new studies for BREAST CANCER (LOCALLY ADVANCED OR METASTATIC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cells engineered to fight advanced breast cancer enter human trials
Disease control Recruiting nowThis study tests a new treatment using specially designed immune cells (CAR-NK cells) that target specific markers on breast cancer cells. It is for people with advanced or metastatic breast cancer, including HER2-positive and triple-negative types, who have tried other treatment…
Matched conditions: BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated May 26, 2026 06:21 UTC
-
Immune cell therapy takes on Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment called EBNK-001, which uses donor immune cells (natural killer cells) to fight advanced solid tumors. About 83 adults with cancers like lung, breast, or colorectal cancer that have not responded to standard treatments will receive these cells alon…
Matched conditions: BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New shot targets tough cancers: early trial seeks 150 patients
Disease control Recruiting nowThis early-stage study tests a new drug called SH009 in about 150 people with advanced solid tumors (like liver, lung, or breast cancer) that have not responded to standard treatments. The main goal is to see if the drug is safe and can shrink tumors. Researchers will also measur…
Matched conditions: BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE1 • Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd. • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
AI app aims to ease cancer treatment side effects
Symptom relief Recruiting nowThis study tests a smartphone app called ASSIST that uses artificial intelligence to help people with breast, colorectal, or lymphoma cancer manage symptoms while receiving chemotherapy or other systemic therapy. About 60 adults will be split into two groups: one uses the app for…
Matched conditions: BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: NA • Sponsor: Patrick C. Johnson, MD • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC
-
Tattoos could help breast cancer patients keep their breasts
Knowledge-focused Recruiting nowThis study tests a simple idea: tattooing the edges of a breast tumor before chemotherapy begins. After chemo shrinks the tumor, the tattoo marks help surgeons find and remove all remaining cancer during breast-conserving surgery. The goal is to see if this approach helps more wo…
Matched conditions: BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: NA • Sponsor: All India Institute of Medical Sciences, Bhubaneswar • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC